Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy von Italiano, A., Massard, C., Bahleda, R., Vataire, A.-L., Deutsch, E., Magné, N., Pignon, J.-P., Vassal, G., Armand, J.-P., Soria, J.-C.

Volltext

Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients von Pittari, G, Fregni, G, Roguet, L, Garcia, A, Vataire, A-L, Wittnebel, S, Amsellem, S, Chouaib, S, Bourhis, J-H, Caignard, A

Volltext

Prediction and Diagnosis of Bone Metastases in Well-Differentiated Gastro-Entero-Pancreatic Endocrine Cancer: A Prospective Comparison of Whole Body Magnetic Resonance Imaging and... von Leboulleux, S., Dromain, C., Vataire, A. L., Malka, D., Aupérin, A., Lumbroso, J., Duvillard, P., Elias, D., Hartl, D. M., De Baere, T., Guigay, J., Schlumberger, M., Ducreux, M., Baudin, E.

Volltext

P.3.f.007 Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics von Vataire, A, Ferchichi, S, Desroziers, K, Cadi-Soussi, N, Murthy, V, Toumi, M

Volltext

PRM149 - OPEN-SOURCE DISCRETE EVENT SIMULATION MODEL FOR MAJOR DEPRESSION DISORDER (MDD): AN UPDATE SUITABLE FOR NEW GENERATION TREATMENT? von Clay, E, Vataire, A, Cristeau, O, Toumi, M

Volltext

PRM147 - OPEN-SOURCE MODELS IN HEALTH ECONOMICS: EXPERIENCE BASED ON A DISCRETE EVENT SIMULATION MODEL IN MAJOR DEPRESSIVE DISORDER von Clay, E, Vataire, A, Cristeau, O, Aballea, S

Volltext

Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma: A Network Meta-Analysis von Lister, J, Schmidt, E, Marteau, F, Vataire, A

Volltext

PCN17 - Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma: A Network Meta-Analysis von Lister, J, Schmidt, E, Marteau, F, Vataire, A

Volltext

HTA339 HTA Agencies' Expectations for Caregiver Quality of Life Considerations in CEA: A Focus on Pediatric Indications von Sutour, L, Allali, N, Vataire, AL

Volltext

PSY125 - Determinants of Orphan Drug Prices in Italy and the UK von Korchagina, D, Millier, A, Toumi, M, Vataire, A, Falissard, B

Volltext

Determinants of Orphan Drug Prices in Italy and the UK von Korchagina, D, Millier, A, Toumi, M, Vataire, A, Falissard, B

Volltext

PRM28 - Review of Methods for Combining Individual and Aggregate Data in a Meta-Analysis von Kapso Kapnang, R, Thokagevistk, K, Vataire, A, Aballéa, S

Volltext

Review of Methods for Combining Individual and Aggregate Data in a Meta-Analysis von Kapso Kapnang, R, Thokagevistk, K, Vataire, A, Aballéa, S

Volltext

Economic Impact of a Genomic Companion Diagnostic Test for Breast Cancer Patients in French Private Hospitals von Vataire, A.L, Aballéa, S, Katz, G

Volltext

Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer von Ma, Xiaoli, Rousseau, Vanessa, Sun, Haiji, Lantuejoul, Sylvie, Filipits, Martin, Pirker, Robert, Popper, Helmut, Mendiboure, Jean, Vataire, Anne-Lise, Le Chevalier, Thierry, Soria, Jean Charles, Brambilla, Elisabeth, Dunant, Ariane, Hainaut, Pierre

Volltext

Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease von Bourgier, Céline, Khodari, Wassim, Vataire, Anne-Lise, Pessoa, Eduardo Lima, Dunant, Ariane, Delaloge, Suzette, Uzan, Catherine, Balleyguier, Corinne, Mathieu, Marie-Christine, Marsiglia, Hugo, Arriagada, Rodrigo

Volltext

PR1 - Determinants of Orphan Drug Prices in France: Regression Analysis von Korchagina, D, Vataire, A, Toumi, M, Falissard, B, Aballéa, S

Volltext

Determinants of Orphan Drug Prices in France: Regression Analysis von Korchagina, D, Vataire, A, Toumi, M, Falissard, B, Aballéa, S

Volltext

PCN159 - The Comparative Cost-Effectiveness of Cabozantinib, Everolimus and Axitinib in Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy: Scottish Perspective von Lister, J, Vataire, A, Amzal, B, Dinet, J, Meng, J, Karcher, H, Gabriel, S

Volltext

Cost-Effectiveness in England of Cabozantinib for Patients with Advanced Renal Cell Carcinoma (ARCC) After Failure of Prior Therapy von Lister, J, Vataire, A, Amzal, B, Dinet, J, Meng, J, Karcher, H, Gabriel, S

Volltext